|
|
|
 |
FDA Approval Activities for this Drug…
Nabumetone Tablets, 500 mg, Second () Copley Pharmaceutical, ANDA 75-179 6/6/00 6/9/00 12/31/01 | Nabumetone Tablets, 500 mg & 750 mg, Teva USA ANDA 75-189 S-01, S-02 9/24/01 4/9/03 | Nabumetone Tablets, 500 mg & 750 mg, Teva USA ANDA 75-189 5/26/00 6/6/00 12/28/01 | Nabumetone Tablets, 500 mg and 750 mg, (Tentatively approved 12/24/98) Teva USA ANDA 75-189 12/24/98 12/24/98 | Nabumetone Tablets, 500 mg and 750 mg, Eon Labs Manufacturing ANDA 75-280 2/25/02 4/10/03 | Nabumetone Tablets, 500 mg and 750 mg, August 6 Eon Labs Manufacturing ANDA 75-280 8/6/98 8/7/98 | Nabumetone Tablets, 500 mg and 750 mg, Invamed ANDA 75-590 2/25/02 | Nabumetone Tablets, 500 mg and 750 mg, 3/21/01 Invamed ANDA 75-590 3/21/01 3/30/01 | Nabumetone Tablets, 500 mg and 750 mg, Ivax ANDA 76-009 NABUMETONE Tablet; 750MG NABUMETONE Copley 075280 NABUMETONE Tablet; 500MG NABUMETONE Eon 075280 NABUMETONE Tablet; 750MG NABUMETONE Eon 019583 NABUMETONE Tablet; 500MG RELAFEN GLAXOSMITHKLINE | 019583 NABUMETONE Tablet; 750MG RELAFEN GLAXOSMITHKLINE | 075590 NABUMETONE Tablet; 500MG NABUMETONE INVAMED | 075590 NABUMETONE Tablet; 750MG NABUMETONE INVAMED | 076009 NABUMETONE Tablet; 500MG NABUMETONE Ivax 076009 NABUMETONE Tablet; 750MG NABUMETONE Ivax 075189 NABUMETONE Tablet; 500MG NABUMETONE Teva | 075189 NABUMETONE Tablet; 750MG NABUMETONE Teva | RELAFEN (nabumetone) Tablet, GlaxoSmithKline, Labeling Revision | Relafen (nabumetone) Tablets, GlaxoSmithKline, Labeling Revision | Nabumetone Tablets, InvaGen Pharma, Approval | Nabumetone Tablets, Dr. Reddy's Laboratories, Ltd., Approval | Nabumetone Tablets, Actavis Elizabeth LLC, Approval | Nabumetone Tablets, Matrix Laboratories Ltd., Approval | Nabumetone Tablets, Lupin Limited, Approval | Nabumetone Tablets, Watson Laboratories, Inc., Approval | Nabumetone, nabumetone, Tablet; Oral, Apotex Inc, Approval
  
|